-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
EF6FpJJjyCVtlNoAgXOh614eb2O+rsRpZjZA8GxjNDdgv7wd4izaF159jRmkka31
+Rq8TM72THZGkIoWBh4nrA==
<SEC-DOCUMENT>0001008925-00-000006.txt : 20031217
<SEC-HEADER>0001008925-00-000006.hdr.sgml : 20031217
<ACCEPTANCE-DATETIME>20000802131200
ACCESSION NUMBER: 0001008925-00-000006
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20000630
FILED AS OF DATE: 20000802
DATE AS OF CHANGE: 20000803
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DUQUESNE CAPITAL MANAGEMENT L L C
CENTRAL INDEX KEY: 0001008925
IRS NUMBER: 251772402
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-03925
FILM NUMBER: 00684317
BUSINESS ADDRESS:
STREET 1: 2579 WASHINGTON ROAD
STREET 2: SUITE 322
CITY: PITTSBURGH
STATE: PA
ZIP: 15241
BUSINESS PHONE: 4128543112
MAIL ADDRESS:
STREET 1: 2579 WASHINGTON ROAD
STREET 2: SUITE 322
CITY: PITTSBURGH
STATE: PA
ZIP: 15241
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>0001.txt
<TEXT>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Report for the Calendar Year or Quarter Ended: June 30, 2000
----------------
Check here if Amendment [_]; Amendment Number: N/A
-------
This Amendment ( Check only one): [_] is a restatement.
[_] adds new holdings entries
Institutional Investment Manager Filing this Report:
Name: Duquesne Capital Management, L.L.C.
----------------------------------------------
Address: 2579 Washington Road, Suite 322
----------------------------------------------
Pittsburgh, PA 15241
----------------------------------------------
----------------------------------------------
The institutional investment manager filing this report and the person by whom
it is signed herby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that is understood that all required items, statements,
schedules, list, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Joseph W. Haleski
-----------------------------------------------
Title: Vice President & Managing Director
-----------------------------------------------
Phone: 412-854-3112
-----------------------------------------------
Signature, Place, and Date of Signing:
/s/ Joseph W. Haleski Pittsburgh, PA 08/2/00
- ---------------------- ------------------- ----------
[Signature] [City, State] [Date]
Report Type
[X] 13F HOLDING REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
<TABLE> <C> <C>
Title Investment Discretion Voting Authority
of
Security Class Cusip Market Value Quantity Sole Share Others Managers Sole Share None
AMGEN INC COM 031162100 $2,262,050.00 32,200 X 32,200
GENENTECH, INC. COM 368710406 $13,777,200.00 80,100 X 80,100
HUMAN GENOME SCIENCES, INC. COM 428236103 $2,174,012.50 16,300 X 16,300
IDEC PHARMACEUTICALS CORP. COM 449370105 $6,428,725.00 54,800 X 54,800
INCYTE PHARMACEUTICALS INC. COM 45337C102 $2,646,437.50 32,200 X 32,200
MILLENNIUM PHARM, INC. COM 599902103 $5,828,687.50 52,100 X 52,100
PE CORP- CELERA GENOMICS GROUP COM 69332S201 $3,543,650.00 37,900 X 37,900
QUALCOMM INCORPORATED COM 747525103 $1,236,000.00 20,600 X 20,600
SEVEN SEAS PETROLEUM INC. COM 817917107 $550,643.76 463,700 X 463,700
SONERA OYJ CORPORATION SPON ADR 835433202 $27,922,000.00 607,000 X 607,000
STORAGENETWORKS, INC. COM 86211E103 $3,203,875.00 35,500 X 35,500
TRIANGLE PHARMACEUTICALS, INC. COM 89589H104 $2,039,062.50 225,0000 X 225,000
GRAND TOTAL $71,612,343.76
</TABLE>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----